POSC131 Events Avoided and Cost Savings Associated with the Use of Intravenous Ferric Carboxymaltose for the Treatment of Iron Deficiency in Patients Stabilized after an Acute Heart Failure Episode with Reduced Ejection Fraction in the UK
Jan 1, 2022, 00:00
10.1016/j.jval.2021.11.535
https://www.valueinhealthjournal.com/article/S1098-3015(21)02330-5/fulltext
Title :
POSC131 Events Avoided and Cost Savings Associated with the Use of Intravenous Ferric Carboxymaltose for the Treatment of Iron Deficiency in Patients Stabilized after an Acute Heart Failure Episode with Reduced Ejection Fraction in the UK
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(21)02330-5&doi=10.1016/j.jval.2021.11.535
First page :
Section Title :
Open access? :
No
Section Order :
10071